[1] 白华, 曲陆荣, 王敬云. 子宫内膜癌中MTS1/p16基因的表达及临床意义初探 [J]. 中国实用妇科与产科杂志 2001.doi:10.3969/j.issn.1005-2216.2001.11.015
[2] 彭广军, 宋洪波, 张淑艳, 曹国辉, 边剑飞, 杨伟红. 胰岛素样生长因子-I在急性进展性脑梗死中的水平及临床意义 [J]. 医学研究与教育 2009.doi:10.3969/j.issn.1674-490X.2009.01.005
[3] 张娜, 熊永炎, ZHANG Na, XIONG Yongyan. P57kip2、IGFⅡ、Cyclin E和Caspase-3蛋白在胃腺癌中的表达及其相关性研究 [J]. 武汉大学学报（医学版） 2007.doi:10.3969/j.issn.1671-8852.2007.01.009
[4] Le Roith D, Clemmons D, Nissley P. Insulin-like growth factors in health and disease [J]. Annals of Internal Medicine 1992, 116(10).
[5] E I-Badry OM, Romanus JA, Helman LJ. Automous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor-II [J]. Journal of Clinical Investigation 1989, 84(03).
[6] Martin DM, Feldman EL. Regulation of insulin-like growth factor-Ⅱ expression and its role in autoerine growth of human neuroblastoma cells [J]. Journal of Cellular Physiology 1993, 155(02).
[7] Recio-Pinto E, Rechler MM, Ishii DN. Effects of insulinlike growth factor-Ⅱ and nerve growth factor on neurite formation and survival in cultured sympathetic and sensory neurons [J]. Journal of Neuroscience 1986, 6(05).
[8] Barres BA, Hart IK, Coles HS. Cell death and control of cell survival in the oligodendroeyte lineage [J]. CELL 1992, 70(01).
[9] Su TS, Liu WY, Han SH, Jansen M. Transcripts of the insulin-like growth factor-Ⅰ and Ⅱ in human hepatoma [J]. Cancer Research 1989, 49(07).
[10] Tricoli JV, Rall LB, Karakousis CP. Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinoma and liposarcomas [J]. Cancer Research 1986, 46(12).
[11] LeRoith D, Roberts CT. The insulin-like growth factor system and cancer. [J]. Cancer letters 2003, 2(2).
[12] Vella V, Sciacca L, Pandini G. The IGF system in thyroid cancer:new concepts [J]. Molecular pathology 2001, 54(03).
[13] Hlert S, Nuedling S, van Eickels M. Estrogen receptor alpha rapidly activates the IGF-Ⅰ Recaptor pathway [J]. Journal of Biological Chemistry 2000, 275(24).
[14] Gielen SC, Hanekamp EE, Blok LJ, Huikeshoven FJ, Burger CW. [J]. Journal of the Society for Gynecologic Investigation 2005.
[15] Peruzzi F, Prisco M, Dews M, Salomoni P, Grassilli E, Romano G, Calabretta B, Baserga R. Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis. [J]. Molecular and Cellular Biology 1999, 10(10).
[16] Moorehead RA, Sanchez OH, Baldwin RM, Khokha R. [J]. Oncogene 2003.
[17] Pavelic K, Kolak T, Kapitanovic S, Radosevic S, Spaventi S, Kruslin B, Pavelic J. [J]. Journal of Pathology: Journal of the Pathological Society of Great Britain and Ireland 2003.
[18] Cardillo MR, Monti S, Di Silverio F, Gentile V, Sciarra F, Toscano V. [J]. Anticancer Research: International Journal of Cancer Research and Treatment 2003.
[19] Papa V, Gliozzo B, Clark GM. Insulin like growth factor recptor-I1(IGFR-1) are overexpressed and predict a low risk in human breast cancer [J]. Cancer Research 1993, 53(16).
[20] Peters MG, Farias E, Colombo L. Inhibition of invasion and metastasis by glypocan-3 in a syngeneic breast cancer model [J]. B-reast Cancer Res Treat 2003, 80(02).
[21] Pavelic' J, Radakovic' B, Pavelic' K. Insulin-like growth factor 2 and its receptors (IGF 1R and IGF 2R/mannose 6-phosphate) in endometrial adenocarcinoma [J]. Gynecologic Oncology 2007, 105(03).
[22] Reynolds, RK, Hu, C, Baker, VV. [J]. Gynecologic Oncology 1998. |
